Supplier
Medrx Compounding & Pharmacy Limited Company
Medrx Compounding & Pharmacy Limited Company was paid $0.00 by Medicaid between May 2023 and May 2023, across 1 billing code. Its largest line is K1034, Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count — 0% of everything it billed.
33Billing provider infoMEDRX COMPOUNDING & PHARMACY LIMITED COMPANY
HOUSTON, TX 77011
HOUSTON, TX 77011
33aNPI1124328034assigned 10/25/2010
33bProvider typeCompounding Pharmacy
28Total paid$0.00
24GClaims26
24DCodes billed1
24AFirst – last monthMay 2023 – May 2023
Compared with peers
Next to other Compounding Pharmacy providers in Texas
Rank by total paid#6 of 8
Median peer was paid$789.68
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 26 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 0% | 26 | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSARPONG, LINDA (DIRECTOR/OWNER)